Asp Isotopes INC 8-K filings

ASP Isotopes Inc. has completed the construction phase of its Ytterbium-176 enrichment plant nine months ahead of schedule, potentially easing supply chain constraints in the growing radiopharmaceutical market.

ASP Isotopes successfully closed its public offering, raising $34.5 million through the sale of 13.8 million shares, including the full exercise of the underwriter's option.

ASP Isotopes has priced a public offering of 12 million shares of common stock at $2.50 per share, aiming to raise $30 million before expenses.

ASP Isotopes Inc. has appointed Heather Kiessling as its new Chief Financial Officer, effective July 1, 2024, to support the company's next phase of growth.

Quantum Leap Energy LLC, a subsidiary of ASP Isotopes Inc., secured approximately $5.4 million in gross proceeds through a convertible note offering to accredited investors.

ASP Isotopes Inc. issued new warrants to Armistice Capital Master Fund Ltd. in exchange for the exercise of existing warrants, generating approximately $5.5 million in gross proceeds.

Quantum Leap Energy, a subsidiary of ASP Isotopes, successfully closed an oversubscribed convertible note offering, raising approximately $20.5 million to fund its laser enrichment production facilities.

ASP Isotopes Inc. reports the resignation of a board member and the appointment of a new director, effective January 14, 2024.